Healthcare Services

Acute Agitation And Aggression Treatment Market Future Analysis Covering Industry Shifts And Growth Potential

May 27, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Market Size Is Forecasted For The Acute Agitation And Aggression Treatment Market By 2030 Based On Its 2026 Value?

The acute agitation and aggression treatment market has experienced robust expansion in its size over the past few years. Forecasts indicate it will expand from $6.05 billion in 2025 to reach $6.36 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 5.2%. This historical expansion is linked to factors such as the rising incidence of psychiatric disorders, an increase in emergency department visits related to agitation, enhanced access to antipsychotic medications, the broadening of mental health services, and greater public awareness of behavioral health issues.

The acute agitation and aggression treatment market size is expected to undergo substantial growth in the next few years. It is forecast to grow to $8.37 billion in 2030, achieving a compound annual growth rate (CAGR) of 7.1%. The expansion witnessed in the forecast period can be attributed to several factors, including the growing demand for fast-acting therapeutic options, increasing investments in neuropsychiatric drug development, the rising use of digital mental health tools, the expansion of integrated behavioral care models, and a stronger focus on patient-centric treatment pathways. Prominent trends expected during this period involve the increasing adoption of rapid-acting pharmacologic treatments, a rising focus on personalized psychiatry approaches, the growing integration of digital monitoring tools, the expansion of emergency behavioral care protocols, and an enhanced emphasis on patient safety.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13078&type=smp

What Key Growth Drivers Are Influencing The Acute Agitation And Aggression Treatment Market?

The rising occurrence of dementia is projected to fuel the expansion of the acute agitation and aggression treatment market in the foreseeable future. Dementia encompasses conditions characterized by impaired memory, cognitive function, and the ability to perform daily tasks. Agitation, often seen in dementia patients, presents as behaviors like restlessness, repetitive actions, or frequent hand movements. Acute agitation and aggression treatment holds significant importance in dementia care, as it lessens the risk of detrimental symptoms, enhances patients’ quality of life, and addresses the fundamental cause of the agitation. For example, in February 2023, information from the Australian Institute of Health and Welfare, an Australia-based government agency, estimated that around 401,300 Australians had dementia in 2022, with this figure expected to double to 849,300 by 2058. Hence, the escalating incidence of dementia is propelling the growth of the acute agitation and aggression treatment market.

How Is Segment Classification Applied In The Acute Agitation And Aggression Treatment Market?

The acute agitation and aggression treatment market covered in this report is segmented –

1) By Treatment Approach: Behavioral Approaches, Environmental Interventions, Pharmacologic Approaches

2) By Drug Class: Anti-Psychotics, Benzodiazepines, Other Drug Classes

3) By Route of Administration: Oral, Intramuscular, Other Routes of Administrations

4) By Indication: Schizophrenia, Dementia, Bipolar Disorder, Depression, Drug-Induced Agitation And Aggression, Alcohol Withdrawal, Other Indications

5) By End User: Hospitals And Ambulatory Surgical Centers, Psychiatric Care Facilities, Other End Users

Subsegments:

1) By Behavioral Approaches: Cognitive Behavioral Therapy (CBT), De-escalation Techniques, Psychoeducation, Relaxation Therapy, Other Behavioral Interventions

2) By Environmental Interventions: Sensory Modifications, Safe Room Or Containment Strategies, Environmental Noise Reduction, Lighting And Temperature Adjustments, Other Environmental Interventions

3) By Pharmacologic Approaches: Antipsychotic Medications, Benzodiazepine Medications, Mood Stabilizers, Other Pharmacologic Agents, Adjunctive Medications

What Trends Are Influencing The Future Of The Acute Agitation And Aggression Treatment Market?

Major companies operating in the acute agitation and aggression treatment market are concentrating on developing innovative products, such as a generic version of Zyprexa, to meet patient needs. Generic Zyprexa is a variation of the brand-name medication Zyprexa, which contains the active ingredient olanzapine and is utilized for treating psychotic conditions. For instance, in September 2023, Camber Pharmaceuticals, a US-based pharmaceutical company, launched a generic version of Zyprexa. This atypical antipsychotic medicine is prescribed for the treatment of acute agitation associated with schizophrenia and bipolar I mania.

Which Companies Are Influencing The Acute Agitation And Aggression Treatment Market?

Major companies operating in the acute agitation and aggression treatment market are Pfizer Inc., Johnson and Johnson Pvt Ltd., F Hoffmann-La Roche Ltd., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, GlaxoSmithKline plc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co Ltd., Mylan NV, Biogen Inc., Bausch Health Companies Inc., UCB SA, Servier Laboratories, Sun Pharmaceutical Industries Ltd., AstraZeneca PLC, Ono Pharmaceutical Co Ltd., Apotex Inc., H Lundbeck A/S, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Neurocrine Biosciences Inc., Aurobindo Pharma Limited, Alkermes plc., Indivior plc., Sunovion Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., and Alexza Pharmaceuticals Inc

Access The Complete Acute Agitation And Aggression Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/acute-agitation-and-aggression-treatment-global-market-report

Which Region Holds The Largest Share In The Acute Agitation And Aggression Treatment Market?

North America was the largest region in the acute agitation and aggression treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute agitation and aggression treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Acute Agitation And Aggression Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=13078&type=smp

Browse Through More Reports Similar to the Global Acute Agitation And Aggression Treatment Market 2026, By The Business Research Company

Telepsychiatry Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/telepsychiatry-global-market-report

Psychedelic Drugs Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report

Neurodegenerative Disorder Therapeutic Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795